Loading data
GMHSNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2023 |
|---|---|---|---|---|---|
| Revenue | 104.65 m USD | 118.05 m USD | 145.24 m USD | — | 168.16 m USD |
| Cost of revenue | 49.48 m USD | 55.86 m USD | 70.66 m USD | — | 71.37 m USD |
| Research and development expense | 6.34 m USD | 5.69 m USD | 4.79 m USD | — | 5.49 m USD |
| Operating profit | 1.38 m USD | 3.39 m USD | 8.35 m USD | — | 3.15 m USD |
| Profit before tax | 3.87 m USD | 3.99 m USD | 8.72 m USD | — | 4.02 m USD |
| Income tax expense | 18.54 k USD | 165.59 k USD | 130.31 k USD | — | -78.74 k USD |
| Net income (reported basis) | 4.28 m USD | 3.96 m USD | 8.25 m USD | 1.5 m USD | 3.79 m USD |
| Net income attributable to common shareholders | 4.28 m USD | 3.96 m USD | 8.25 m USD | — | 3.79 m USD |
| Basic earnings per share | 0.08 USD/share | 0.08 USD/share | 0.16 USD/share | — | 0.08 USD/share |
| Diluted earnings per share | 0.08 USD/share | 0.08 USD/share | 0.16 USD/share | — | 0.08 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.